News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Breast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue)
ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer

16/11/17

The Institute of Cancer Research, London, welcomes the approval by NICE of a new type of treatment for women with previously untreated advanced breast cancer.
Breast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue)
New treatment approach for rare type of ‘triple negative’ breast cancers identified

22/09/17

Leading scientists funded by Breast Cancer Now have identified a potential new treatment approach for some ‘triple negative’ breast cancers (TNBCs).
blood samples in test tube
New three-in-one blood test opens door to precision medicine for prostate cancer

19/06/17

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.
Breast cancer cell
Experimental drug could lead to potent combination in breast and other cancers

20/04/17

An experimental drug could be used in combination with chemotherapy as a treatment for breast and other cancers, new research shows.
ICR Logo
Scientists create artificial ‘mini tumours’ to study cancer genes

30/03/17

A new technique to screen clumps of cancer cells in the lab which act like miniature tumours could help scientists discover potential new cancer drugs.
The ICR logo on the Brookes Lawley Building
The ICR responds to decision by NICE not to recommend palbociclib

03/02/17

The Institute of Cancer Research, London, has expressed disappointment that the breast cancer drug palbociclib will not be made available to patients and is calling for urgent discussions to reduce the price of the drug.
ICR Logo
Gene test could pinpoint patients sensitive to new type of cancer drug

22/12/16

Testing for a gene commonly mutated in ovarian cancers could pick out patients who will respond well to a promising new class of cancer drugs, a major new study reveals.
chris tape image content
Top 10 scientific achievements of 2016

12/12/16

We've selected our top 10 discoveries of 2015/16 – chosen because they best represent the breadth of our research and our ambitions under the new research strategy.
Fruit fly (Drosophila melanogaster, male), by Max Westby / Creative Commons BY-NC-SA
Relish is pickled to protect flies from immunogenic havoc

03/11/16

Two proteins called Pickle and Relish help to keep fruit flies healthy, a new study shows.
ICR Logo
Study shows blood vessel cells are helping breast cancers enter bloodstream and spread around body

15/09/16

Scientists have discovered that non-cancer cells that wrap around blood vessels — called ‘pericytes’ — are helping breast cancer cells enter the bloodstream and spread around the body through the production of a key molecule called endosialin.
ICR Logo
Blood test to spot new breast cancer subtype delays progression for twice as long

01/09/16

A blood test that detects when the most common form of breast cancer has become resistant to treatment could double the average time it takes for the disease to progress, from around two-and-a-half to around six months, a new study shows.
ICR Logo
Leukaemia drug shows potential for rarer type of ovarian cancer

30/06/16

A drug already approved for leukaemia patients could also be used to treat a specific type of ovarian cancer, according to new research.


Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.